Home・Stock List・Medtronic PLC

Medtronic PLC

Closed

SectorHealthcare

90.57 -0.71

Buy Sell

Overview

Share price change

24h

Current

Min

90.89

Max

91.85

Key metrics
By Trading Economics
Income	130M 1.3B
Sales	789M 9.8B
P/E Sector Avg	23.345 57.002
EPS	1.55
Dividend yield	3.26
Profit margin	12.981
Employees	95,000
EBITDA	147M 2.6B

Recommendations
By TipRanks
Recommendations	Buy
12 Months Forecast	+4.67% upside

Dividends
By Acuity
Dividend yield Sector Avg	3.26% 2.22%
Next Earnings	1 Sept 2026
Next Dividend date	16 Oct 2026
Next Ex Dividend date	25 Sept 2026

Market Stats
By TradingEconomics
Market Cap	14B 109B
Previous open	91.28
Previous close	90.57

News Sentiment

By Acuity

39%

61%

111 / 340 Healthcare

Medtronic PLC Chart

Past performance is not a reliable indicator of future results.

Related News

14 Aug 2026, 21:51 UTC

Medtronic PLC shares are lower in after-market hours, with no specific news cited. Broader market declines follow a report of falling U.S. retail sales.

13 Aug 2026, 23:01 UTC

Medtronic PLC shares are lower in after-market hours, continuing a decline from earlier losses amid mixed signals on labor market strength and inflation.

12 Aug 2026, 23:01 UTC

Medtronic PLC shares are lower in after-market trading, reflecting a retracement from an earlier peak while remaining above the 20-day moving average.

11 Aug 2026, 23:01 UTC

Shares of Medtronic PLC were lower during after-market hours, despite a brief uptick earlier in the session. No specific news was identified.

10 Aug 2026, 23:21 UTC

Medtronic PLC shares are higher in after-market trading, continuing an upward trend since Monday's close and remaining above the 20-day moving average.

8 Aug 2026, 00:02 UTC

Medtronic PLC shares are lower in after-market hours amid a volatile session. A weak jobs report has influenced broader market expectations for interest rate hikes.

7 Aug 2026, 23:26 UTC

Medtronic PLC shares are higher in after-market hours, supported by overall market strength and strong performances from major tech stocks.

6 Aug 2026, 20:06 UTC

News

Medtronic PLC announced expanded CE Mark approval for its Sphere-9 Catheter, yet shares are trading lower since Wednesday's close after an earlier uptick.

5 Aug 2026, 19:52 UTC

News

Medtronic PLC shares are lower today amid increased put options volume, reflecting bearish sentiment ahead of the upcoming earnings report on September 1st.

4 Aug 2026, 20:06 UTC

News

Medtronic PLC shares are lower after a jury ruled the company owes $88 million for damages related to Covidien's hernia mesh products.

3 Aug 2026, 23:02 UTC

Medtronic PLC shares are lower in after-market hours, reflecting selling pressure despite trading above its 20-day moving average. No specific news was identified.

31 Jul 2026, 23:46 UTC

Medtronic PLC shares are trading higher in after-market hours, following unusual trading activity and amid rising U.S. Treasury yields and crude oil prices.

30 Jul 2026, 23:31 UTC

Medtronic PLC shares are modestly higher in after-market trading, remaining near the upper end of their one-month range. No specific news was identified.

29 Jul 2026, 21:51 UTC

Medtronic PLC shares are lower in after-market hours, reflecting broader market declines amid renewed inflation and interest rate concerns linked to rising crude oil prices.

28 Jul 2026, 23:26 UTC

Shares of Medtronic PLC are trading higher in after-market hours, maintaining above the 20-day moving average amid a trend of five consecutive daily gains.

27 Jul 2026, 23:46 UTC

Medtronic PLC shares are trading higher in after-market hours, continuing an upward trend and supported by positive sentiment in European markets.

24 Jul 2026, 23:26 UTC

Medtronic PLC's after-market trading remains roughly flat, showing routine performance within a narrow range since Friday's close.

23 Jul 2026, 23:02 UTC

Medtronic PLC shares are trading higher in after-market hours, reaching near the top of their one-month trading range amid broader market stability.

22 Jul 2026, 19:36 UTC

News

Medtronic PLC shares are lower as competition increases from Johnson & Johnson's newly authorized Ottava Surgical Robot for U.S. robotic soft-tissue surgery.

21 Jul 2026, 20:07 UTC

News

Medtronic PLC shares are lower today, impacted by declines in the Health Care Equipment sector. The company recently launched its AI-native surgical platform, Touch Surgery™ Aide.

20 Jul 2026, 22:31 UTC

Medtronic PLC shares are higher in after-market hours, reflecting positive movement in the Health Care Equipment sub-sector. The stock remains above its 20-day moving average.

Peer Comparison

Price change

Medtronic PLC Forecast

Price Target

By TipRanks

4.67% upside

12 Months Forecast

Average 95.53 USD 4.67%

High 118 USD

Low 80 USD

Based on 19 Wall Street analysts offering 12 month price targets forMedtronic PLC - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

19 ratings

Buy

Hold

Sell

Based on 19 analysts giving stock ratings to Medtronic PLC - Dist in the past 3 months.

Sentiment

By Acuity

111 / 340 Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Medtronic PLC

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. The segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists; and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat other non-exclusive diseases and conditions; and patient monitoring and airway management products. The Diabetes Operating Unit segment provides insulin pumps and consumables, continuous glucose monitoring systems, and InPen, a smart insulin pen system. The company was founded in 1949 and is headquartered in Galway, Ireland.